AzTrials
AzTrials

StrokeVIPERSNCT07254949

Vision and Proprioception Evaluation With Robotics After Stroke

An observational study of Stroke and Control Condition, run by Dr. Sean Dukelow at 2 sites in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Stroke is highly prevalent in Canada and can lead to profound upper limb impairments in motor and sensory function, as well and vision. Clinical assessments for these functions often lack sensitivity making detecting impairments and tracking their recovery after stroke difficult. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, Control Condition
How many people
425 participants
Where
2 sitesCanada
Study dates
Jan 2026to Jun 2031
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 425 participants will be recruited for this study (225 stroke participants and 200 matched control participants who have not experienced a stroke). All participant will be aged 18 or older.

Who may be able to join

  • 18 years of age or older
  • First clinical diagnosis of stroke
  • No recent muscle skeletal injuries to the arms, neck, or back
  • No history of other neurological disease/injury (Ie. MS, Parkinson's, Brain Tumour, etc.)
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands.
Show all 16Show fewer
  • Living independently prior to stroke
  • Can consent to participate in research
  • 18 years of age or older
  • No history stroke, or Trans Ischemic Attack (TIA)
  • No recent muscle skeletal injures to the arms, neck, or back
  • No history of other neurological disease/ injury (Ie. MS, Parkinson's, Brain Tumour, etc)
  • No pre-stroke history of eye movement disorders
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands
  • Can consent to participate in research

Who cannot join

  • Prior history of stroke/significant neurologic problem (e.g. Parkinson's)
  • Symptomatic medical conditions that would interfere with participation (e.g. uncontrolled angina)
  • Contraindications to Magnetic Resonance Imaging (MRI)
  • Pre-stroke history of visual field/oculomotor abnormalities.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Canada2 sites
  • Carewest Dr. Vernon Fanning Centre

    Calgary, Alberta

    Rachel Stone, 403-944-4050, robotlab@ucalgary.ca

  • Foothills Medical Centre

    Calgary, Alberta

    Rachel Stone, 403-944-4050, robotlab@ucalgary.ca

Other trials in Canada

About this study

Stroke is highly prevalent in Canada and can lead to profound upper limb impairments in motor and sensory function, as well and vision. Clinical assessments for these functions often lack sensitivity making detecting impairments and tracking their recovery after stroke difficult. It is known that sensory function and vision interact to inform motor behaviours, yet how each of these modalities might contribute to motor impairments and subsequent recovery after stroke is undetermined.

Using robotics to assess neurologic function after a stroke can be very beneficial, as they can measure on the scale of millimetres and milliseconds which can more easily detect subtle deficits in a persons function. Compared to current clinical tools, robotics offer greater objectivity and reliability, as they do not rely on the examiners clinical experience and/or impression. The use of robotics not only offers a more precise measurement, but robotics assessments can be completed in a relatively short amount of time, in comparison to some of the current clinical assessment tools, which can take along time to complete. In addition to robotics, collecting neuroimaging (MRI/CT) will allow us to relate our robotic and eye-tracking measures to neuroanatomical information about the person's stroke. With this data, we will assess how the brain changes post-stroke in relation to the recovery of motor, sensory and visual functions.

Read more

This research will: 1) examine the relationship between visual and proprioceptive impairment on motor and eye movement behaviour over time after stroke, and 2) identify neuroanatomical correlates of visual, proprioceptive and sensory integrative dysfunction that impact motor recovery after stroke and examine the ability of regional damage and network disruption to predict recovery.

Objectives:

  1. Determine the impact of visual field loss and visual neglect in stroke survivors with impaired movement over the first 6 months post-stroke.
  2. Identify the impact of Proprioceptive Impairment and Sensory Integration Impairment on recovery post-stroke using robotics and eye tracking.
  3. Understand the impact of damage to neuroanatomic structures involved in vision, proprioception and sensory integration on motor recovery using MRI after stroke.

The VIPERS study is recruiting both stroke and control participants. Stroke participants are recruited within the first 28 days post-stroke and are assessed longitudinally across the first 6-months post-stroke (four study timepoints). Control participants just complete a single session.

Keywords
Stroke, Sensation, Movement, Vision, Robotics, Eye-Tracking, Imaging
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07254949
Study groupRoleWhat they receive
StrokeStroke Participants - Individuals with first time stroke
ControlControl Participants - Individuals not suffering stroke or other neurological disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visually Guided Reaching Score

    Measured: Enrolment to six-months post stroke

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Nov 2025
  2. Study startJan 2026 (estimated)
  3. Primary completionJan 2031 (estimated)
  4. Study completionJun 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
425 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07254949
Sponsor's protocol ID
REB25-1170
Other IDs
197953
Acronym
VIPERS
Status last verified
Nov 2025
First submitted
19 Nov 2025
Last updated
28 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Formal data transfer agreements/legal contracts are required to share IPD with other researchers outside of the main study site.

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Control Condition, run by Dr. Sean Dukelow at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visually Guided Reaching Score (time frame: Enrolment to six-months post stroke). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
VIPERS Clinical Trial NCT07254949 | AzTrials